Citadel Advisors
STJ

Citadel Advisors’s St Jude Medical STJ Stock Holding History

Citadel Advisors’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-5,000
Closed -$401K – 8534
2016
Q4 		$401K Sell
5,000
-2,500
-33% -$198K ﹤0.01% 5251
2016
Q3 		$598K Buy
7,500
+1,200
+19% +$96.9K ﹤0.01% 4576
2016
Q2 		$491K Sell
6,300
-36,700
-85% -$2.62M ﹤0.01% 4509
2016
Q1 		$2.37M Buy
43,000
+29,400
+216% +$1.6M ﹤0.01% 2469
2015
Q4 		$840K Sell
13,600
-7,900
-37% -$498K ﹤0.01% 3796
2015
Q3 		$1.36M Sell
21,500
-6,200
-22% -$443K ﹤0.01% 3411
2015
Q2 		$2.02M Buy
27,700
+13,900
+101% +$1M ﹤0.01% 3050
2015
Q1 		$903K Sell
13,800
-4,500
-25% -$299K ﹤0.01% 4059
2014
Q4 		$1.19M Sell
18,300
-8,100
-31% -$522K ﹤0.01% 3550
2014
Q3 		$1.59M Buy
26,400
+1,400
+6% +$91.5K ﹤0.01% 3128
2014
Q2 		$1.73M Buy
25,000
+8,900
+55% +$577K ﹤0.01% 2871
2014
Q1 		$1.05M Sell
16,100
-23,200
-59% -$1.51M ﹤0.01% 3357
2013
Q4 		$2.44M Buy
39,300
+7,000
+22% +$405K ﹤0.01% 2348
2013
Q3 		$1.73M Sell
32,300
-21,300
-40% -$1.1M ﹤0.01% 2553
2013
Q2 		$2.45M Buy
+53,600
New +$2.32M ﹤0.01% 2300

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Citadel Advisors's STJ Position: Q4 2016 in Review

Citadel Advisors sold out of St Jude Medical (STJ) in Q4 2016, closing a stake of 49,900 shares — an estimated $3.96M sold.

Citadel Advisors first reported a position in STJ in Q2 2013 and held it in 13 quarters. The position peaked at $65.1M in Q1 2014. 551 funds tracked by Wall St. Rank hold STJ as of Q4 2016.

  • Citadel Advisors reported no remaining St Jude Medical position as of Q4 2016 after selling out during the quarter.
  • Citadel Advisors sold 49,900 St Jude Medical shares in Q4 2016, an estimated $3.96M.
  • Citadel Advisors first reported a position in St Jude Medical in Q2 2013 and held it in 13 quarters.
  • Citadel Advisors's St Jude Medical position peaked at $65.1M in Q1 2014.
  • 551 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2016.

Based on Citadel Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.